Clinical Trial Update: The Raltegravir and Ribavirin Pharmacokinetics (PK) Study [Phase 1]

View source ↗

Summary

Phase 1 PK study examining raltegravir and ribavirin in HIV infections; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Raltegravir (raltegravir)
• Ribavirin (ribavirin)

Snippet

Sponsor: Imperial College London | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2011-06-13